Aspira is Transforming Women’s Health with an Innovative Solution
Offering Protein Biomarker and Genetic Testing options to provide greater physician insights, facilitate early detection and optimize treatment plans.
- Over 10 years of experience in Ovarian Cancer Risk assessment and Pelvic mass management
- Cutting edge bioinformatics for analysis and data management
- Experienced in quality-focused patient care
- Laboratory Research focused on innovative discovery
Want to Learn More About Our Products?
-
OVA1plus Protein Biomarkers
EXPLORE HEREOvarian Cancer Risk Assessment for women with adnexal masses
-
Aspira GenetiX Testing
EXPLORE HEREHereditary Breast and Ovarian Cancer Genetic Testing, Carrier Screening for Autosomal Recessive and X-Linked Recessive Disorders